Expanding Preclinical Research in the India CRO Market
The India CRO Market is witnessing rapid growth in preclinical research services. CROs are expanding their capabilities in toxicology, pharmacology, and disease modeling to support early-stage drug development. Advanced laboratory infrastructure, combined with skilled researchers, allows India to deliver high-quality preclinical data at competitive prices. Collaborations with academic institutions and biotech startups are further enhancing innovation in this segment. With increasing demand for specialized studies in oncology, rare diseases, and regenerative medicine, Indian CROs are well-positioned to capture a larger share of the global preclinical market. Investment in cutting-edge technology and compliance with international standards will be key to sustaining this momentum.